NASDAQ:AVRO
AVROBIO Inc Stock News
$1.26
+0.0100 (+0.80%)
At Close: May 08, 2024
AVROBIO Inc. (AVRO) Reprioritizes Pipeline Programs, Presentation - Slideshow
04:50pm, Monday, 07'th Feb 2022 Seeking AlphaHere's Why AVROBIO, Inc. (AVRO) is Poised for a Turnaround After Losing 19.7% in 4 Weeks
11:30am, Thursday, 03'rd Feb 2022
The heavy selling pressure might have exhausted for AVROBIO, Inc. (AVRO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analy
AVROBIO to Present at Cowen's 2nd Annual Genetic Medicines Summit
07:00am, Friday, 28'th Jan 2022
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AVRO--AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a shared purpose to free people from a lifetime of genetic disease, today
AVROBIO to Present New Data from Phase 1/2 Clinical Trial in Cystinosis at WORLDSymposium™ 2022
07:00am, Thursday, 27'th Jan 2022
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AVRO--AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announc
AvroBio Inc Shares Near 52-Week Low - Market Mover
02:08am, Sunday, 09'th Jan 2022 Kwhen Finance
AvroBio Inc (AVRO) shares closed today at 0.5% above its 52 week low of $2.11, giving the company a market cap of $92M. The stock is currently down 44.9% year-to-date, down 86.5% over the past 12 months, and down 93.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 142.7% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.6. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 2724.7% The company's stock price performance over the past 12 months lags the peer average by 180.8%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
Here's Why AVROBIO, Inc. (AVRO) is Poised for a Turnaround After Losing 44.1% in 4 Weeks
11:33am, Friday, 07'th Jan 2022
AVROBIO, Inc. (AVRO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estim
AvroBio Inc Shares Fall 1.3% Below Previous 52-Week Low - Market Mover
09:02am, Friday, 07'th Jan 2022 Kwhen Finance
AvroBio Inc (AVRO) shares closed 1.3% lower than its previous 52 week low, giving the company a market cap of $99M. The stock is currently down 40.5% year-to-date, down 84.0% over the past 12 months, and down 92.7% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 234.5% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.6. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 5026.9% The company's stock price performance over the past 12 months lags the peer average by 175.5%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
AVROBIO grants (NASDAQ:AVRO)
01:00pm, Thursday, 06'th Jan 2022 Seeking Alpha
AVROBIO (AVRO) granted non-statutory stock options for the purchase of up to 30.5K shares to three new employees as inducement awards.The stock options were granted on Jan
Avrobio Stock (AVRO): Why The Price Substantially Fell
01:30am, Wednesday, 05'th Jan 2022
The stock price of Avrobio Inc (NASDAQ: AVRO) fell by 36.63% in the most recent trading session. This is why it happened.
AVROBIO down 30% as it reprioritizes pipeline programs
02:52pm, Tuesday, 04'th Jan 2022
AVROBIO Inc (NASDAQ: AVRO) dropped by 30% after announcing it was changing its portfolio priorities to concentrate on other clinical-stage pipeline programs. The company plans to deprioritize the Fab
Analyzing Codiak BioSciences (NASDAQ:CDAK) & AVROBIO (NASDAQ:AVRO)
10:20am, Wednesday, 22'nd Dec 2021 Transcript Daily
Codiak BioSciences (NASDAQ:CDAK) and AVROBIO (NASDAQ:AVRO) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, dividends, risk and institutional ownership. Risk & Volatility Codiak BioSciences has a beta of 4.13, indicating that its share price is []
Codiak BioSciences (NASDAQ:CDAK) and AVROBIO (NASDAQ:AVRO) Critical Contrast
10:20am, Wednesday, 22'nd Dec 2021 Dakota Financial News
Codiak BioSciences (NASDAQ:CDAK) and AVROBIO (NASDAQ:AVRO) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, valuation and institutional ownership. Volatility and Risk Codiak BioSciences has a beta of 4.13, suggesting that its stock price is []
Bioinformatics Global Market Research Report 2021 Featuring Agilent Technologies, Illumina, QIAGEN, Affymetrix and Thermo Fisher Scientific - ResearchAndMarkets.com
05:28pm, Tuesday, 21'st Dec 2021 Kwhen FinanceAVROBIO Inc. (NASDAQ: AVRO) Stocks Fall -73.24% YTD; What Next For It?
03:00pm, Saturday, 11'th Dec 2021 Marketing Sentinel
AVROBIO Inc. (NASDAQ:AVRO)s traded shares stood at 0.73 million during the last session, with the companys beta value hitting 1.40. At the close of trading, the stocks price was $3.73, to imply a decrease of -6.52% or -$0.26 in intraday trading. The AVRO shares 52-week high remains $20.07, putting it -438.07% down since that peak AVROBIO Inc. (NASDAQ: AVRO) Stocks Fall -73.24% YTD; What Next For It? Read More »
AvroBio Inc Shares Close in on 52-Week Low - Market Mover
01:03pm, Saturday, 27'th Nov 2021 Kwhen Finance
AvroBio Inc (AVRO) shares closed today at 1.5% above its 52 week low of $4.02, giving the company a market cap of $178M. The stock is currently down 70.7% year-to-date, down 70.9% over the past 12 months, and down 86.9% over the past five years. This week, the Dow Jones Industrial Average fell 1.9%, and the S&P 500 fell 2.1%. Trading Activity Trading volume this week was 312.2% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.7. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 124.6% The company's stock price performance over the past 12 months lags the peer average by 178.6%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.